IOL Chemicals & Pharmaceuticals Ltd. (IN:IOLCP)
:IOLCP
Want to see IN:IOLCP full AI Analyst Report?
IOLCP Stock Chart & Stats
₹84.09
-₹4.90(-1.13%)
At close: 4:00 PM EST
₹84.09
-₹4.90(-1.13%)
Day’s Range― - ―
52-Week Range₹67.14 - ₹139.85
Previous CloseN/A
Volume410.76K
Average Volume (3M)113.78K
Market Cap
₹39.19B
Enterprise Value₹36.37B
Total Cash (Recent Filing)₹1.79B
Total Debt (Recent Filing)₹1.59B
Price to Earnings (P/E)26.9
Beta1.64
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)3.95
Shares Outstanding293,527,500
10 Day Avg. Volume248,884
30 Day Avg. Volume113,785
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)1.19
Price to Sales (P/S)0.92
P/FCF Ratio55.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.7
Revenue Forecast (FY)₹26.48B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a materially larger equity base provide enduring financial resilience. This structural strength reduces funding costs, increases capacity to absorb shocks, and preserves optionality for strategic investment or targeted M&A without materially increasing solvency risk.
Diversified Business SegmentsOperating across APIs and specialty chemicals gives multiple end markets and revenue streams. Structural diversification lowers single-market concentration risk, supports volume flexibility across cycles, and enables operational leverage from shared manufacturing and distribution capabilities.
Operating Profitability & Revenue ReboundA modest topline rebound together with sustainable operating margins shows the core business can generate recurring operating profits. Consistent EBIT/EBITDA margins support reinvestment for growth and indicate underlying manufacturing competitiveness despite compressed net margins.
Bears Say
Material Margin CompressionSharp erosion from prior peaks indicates lasting pressure on pricing, mix, or cost structure. Lower margins reduce retained earnings, constrain reinvestment or dividend capacity, and signal potential structural competitiveness issues that could persist absent margin recovery or cost transformation.
Weak & Volatile Cash GenerationInconsistent cash conversion and intermittent negative free cash flow limit the firm's ability to fund capex, pay steady dividends, or de-lever without raising external capital. Structurally weak cash generation increases refinancing and execution risk for longer-term strategic initiatives.
Normalized, Lower Returns On EquityA sustained drop in ROE reflects reduced capital efficiency and earnings potency relative to historical levels. Lower returns constrain shareholder value creation, may lower investor confidence in growth reinvestment, and suggest the company faces structural hurdles to regain prior profitability.
IOL Chemicals & Pharmaceuticals Ltd. News
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹67.14 and its highest was ₹139.85 in the past 12 months.
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹39.19B.
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 51 days.
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.8.
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.97%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.466%.
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:IOLCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Technical Analysis
Aarti Drugs Limited
―
Granules India Limited
―
Hikal Limited
―
Neuland Laboratories Ltd.
―
Solara Active Pharma Sciences Ltd.
―